WEKO3
アイテム
{"_buckets": {"deposit": "9d7e999a-9b4f-4afa-84cf-f968e94b360b"}, "_deposit": {"created_by": 1, "id": "48598", "owners": [1], "pid": {"revision_id": 0, "type": "depid", "value": "48598"}, "status": "published"}, "_oai": {"id": "oai:repo.qst.go.jp:00048598", "sets": ["1"]}, "author_link": ["488678", "488683", "488671", "488675", "488679", "488670", "488677", "488673", "488672", "488684", "488669", "488680", "488674", "488681", "488676", "488682"], "item_8_biblio_info_7": {"attribute_name": "書誌情報", "attribute_value_mlt": [{"bibliographicIssueDates": {"bibliographicIssueDate": "2017-07", "bibliographicIssueDateType": "Issued"}, "bibliographicIssueNumber": "7", "bibliographicPageEnd": "938", "bibliographicPageStart": "932", "bibliographicVolumeNumber": "116", "bibliographic_titles": [{"bibliographic_title": "Journal of surgical oncology"}]}]}, "item_8_description_5": {"attribute_name": "抄録", "attribute_value_mlt": [{"subitem_description": "BACKGROUND: The safety and effectiveness of carbon-ion radiotherapy (CIRT) for isolated para-aortic lymph node (PALN) metastasis was evaluated retrospectively.\nMETHODS: CIRT for isolated PALN metastasis from CRC was performed in 34 cases from June 2006 to August 2015 in our institute. A median dose of 52.8 Gy(RBE) (range, 48-52.8 Gy(RBE)) was delivered with a median daily dose of 4.4 Gy(RBE) (range, 4.0-4.4 Gy(RBE)).\nRESULTS: The median follow-up duration for all patients was 24.4 months (range, 7-82.8 months). There were 13 cases (38.2%) who achieved complete response after treatment. The local control rates at 2 and 3 years were 70.1% and 70.1%, respectively. The overall survival rates at 2 and 3 years were 83.3% and 63.0%, respectively. The 3-year survival rates for Stage I-III were 68.7%, while those for Stage IV was 0%. The overall survival of cases with rectal cancer or with high CA19-9 values pre-CIRT tended to be worse. The median survival period was 41.7 months. Twelve of the 34 patients survived for more than 3 years. There were no adverse effects of Grade 3 or higher.\nCONCLUSIONS: CIRT for isolated PALN recurrence after curative resection for CRC appears effective and safe, and it is considered a promising therapy.", "subitem_description_type": "Abstract"}]}, "item_8_publisher_8": {"attribute_name": "出版者", "attribute_value_mlt": [{"subitem_publisher": " Wiley "}]}, "item_8_relation_13": {"attribute_name": "PubMed番号", "attribute_value_mlt": [{"subitem_relation_type_id": {"subitem_relation_type_id_text": "28727901", "subitem_relation_type_select": "PMID"}}]}, "item_8_relation_14": {"attribute_name": "DOI", "attribute_value_mlt": [{"subitem_relation_type_id": {"subitem_relation_type_id_text": "10.1002/jso.24757 ", "subitem_relation_type_select": "DOI"}}]}, "item_8_source_id_9": {"attribute_name": "ISSN", "attribute_value_mlt": [{"subitem_source_identifier": "0022-4790", "subitem_source_identifier_type": "ISSN"}]}, "item_access_right": {"attribute_name": "アクセス権", "attribute_value_mlt": [{"subitem_access_right": "metadata only access", "subitem_access_right_uri": "http://purl.org/coar/access_right/c_14cb"}]}, "item_creator": {"attribute_name": "著者", "attribute_type": "creator", "attribute_value_mlt": [{"creatorNames": [{"creatorName": "Isozaki, Yuka"}], "nameIdentifiers": [{"nameIdentifier": "488669", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Yamada, Shigeru"}], "nameIdentifiers": [{"nameIdentifier": "488670", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Kawashiro, Shohei"}], "nameIdentifiers": [{"nameIdentifier": "488671", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Yasuda, Shigeo"}], "nameIdentifiers": [{"nameIdentifier": "488672", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Okada, Naomi"}], "nameIdentifiers": [{"nameIdentifier": "488673", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Ebner, Daniel"}], "nameIdentifiers": [{"nameIdentifier": "488674", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Tsuji, Hiroshi"}], "nameIdentifiers": [{"nameIdentifier": "488675", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Kamada, Tadashi"}], "nameIdentifiers": [{"nameIdentifier": "488676", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "磯崎 由佳", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "488677", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "山田 滋", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "488678", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "川城 壮平", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "488679", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "安田 茂雄", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "488680", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "岡田 直美", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "488681", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "エブナー ダニエル", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "488682", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "辻 比呂志", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "488683", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "鎌田 正", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "488684", "nameIdentifierScheme": "WEKO"}]}]}, "item_language": {"attribute_name": "言語", "attribute_value_mlt": [{"subitem_language": "eng"}]}, "item_resource_type": {"attribute_name": "資源タイプ", "attribute_value_mlt": [{"resourcetype": "journal article", "resourceuri": "http://purl.org/coar/resource_type/c_6501"}]}, "item_title": "Carbon-ion radiotherapy for isolated para-aortic lymph node recurrence from colorectal cancer.", "item_titles": {"attribute_name": "タイトル", "attribute_value_mlt": [{"subitem_title": "Carbon-ion radiotherapy for isolated para-aortic lymph node recurrence from colorectal cancer."}]}, "item_type_id": "8", "owner": "1", "path": ["1"], "permalink_uri": "https://repo.qst.go.jp/records/48598", "pubdate": {"attribute_name": "公開日", "attribute_value": "2018-03-19"}, "publish_date": "2018-03-19", "publish_status": "0", "recid": "48598", "relation": {}, "relation_version_is_last": true, "title": ["Carbon-ion radiotherapy for isolated para-aortic lymph node recurrence from colorectal cancer."], "weko_shared_id": -1}
Carbon-ion radiotherapy for isolated para-aortic lymph node recurrence from colorectal cancer.
https://repo.qst.go.jp/records/48598
https://repo.qst.go.jp/records/485981f42995b-c7fb-4675-a89d-d086986ec03c
Item type | 学術雑誌論文 / Journal Article(1) | |||||
---|---|---|---|---|---|---|
公開日 | 2018-03-19 | |||||
タイトル | ||||||
タイトル | Carbon-ion radiotherapy for isolated para-aortic lymph node recurrence from colorectal cancer. | |||||
言語 | ||||||
言語 | eng | |||||
資源タイプ | ||||||
資源タイプ識別子 | http://purl.org/coar/resource_type/c_6501 | |||||
資源タイプ | journal article | |||||
アクセス権 | ||||||
アクセス権 | metadata only access | |||||
アクセス権URI | http://purl.org/coar/access_right/c_14cb | |||||
著者 |
Isozaki, Yuka
× Isozaki, Yuka× Yamada, Shigeru× Kawashiro, Shohei× Yasuda, Shigeo× Okada, Naomi× Ebner, Daniel× Tsuji, Hiroshi× Kamada, Tadashi× 磯崎 由佳× 山田 滋× 川城 壮平× 安田 茂雄× 岡田 直美× エブナー ダニエル× 辻 比呂志× 鎌田 正 |
|||||
抄録 | ||||||
内容記述タイプ | Abstract | |||||
内容記述 | BACKGROUND: The safety and effectiveness of carbon-ion radiotherapy (CIRT) for isolated para-aortic lymph node (PALN) metastasis was evaluated retrospectively. METHODS: CIRT for isolated PALN metastasis from CRC was performed in 34 cases from June 2006 to August 2015 in our institute. A median dose of 52.8 Gy(RBE) (range, 48-52.8 Gy(RBE)) was delivered with a median daily dose of 4.4 Gy(RBE) (range, 4.0-4.4 Gy(RBE)). RESULTS: The median follow-up duration for all patients was 24.4 months (range, 7-82.8 months). There were 13 cases (38.2%) who achieved complete response after treatment. The local control rates at 2 and 3 years were 70.1% and 70.1%, respectively. The overall survival rates at 2 and 3 years were 83.3% and 63.0%, respectively. The 3-year survival rates for Stage I-III were 68.7%, while those for Stage IV was 0%. The overall survival of cases with rectal cancer or with high CA19-9 values pre-CIRT tended to be worse. The median survival period was 41.7 months. Twelve of the 34 patients survived for more than 3 years. There were no adverse effects of Grade 3 or higher. CONCLUSIONS: CIRT for isolated PALN recurrence after curative resection for CRC appears effective and safe, and it is considered a promising therapy. |
|||||
書誌情報 |
Journal of surgical oncology 巻 116, 号 7, p. 932-938, 発行日 2017-07 |
|||||
出版者 | ||||||
出版者 | Wiley | |||||
ISSN | ||||||
収録物識別子タイプ | ISSN | |||||
収録物識別子 | 0022-4790 | |||||
PubMed番号 | ||||||
識別子タイプ | PMID | |||||
関連識別子 | 28727901 | |||||
DOI | ||||||
識別子タイプ | DOI | |||||
関連識別子 | 10.1002/jso.24757 |